to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review.
Trospium chloride in the management of overactive bladder.
Tolterodine for the treatment of overactive bladder: a review.
Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia.
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
Update on overactive bladder: pharmacologic approaches on the horizon.
The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW.
Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.
Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia.
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.